The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.60
Bid: 151.00
Ask: 152.00
Change: 1.20 (0.80%)
Spread: 1.00 (0.662%)
Open: 150.80
High: 152.80
Low: 150.80
Prev. Close: 150.40
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2022 Final Results

2 Mar 2023 07:00

RNS Number : 5867R
Apax Global Alpha Limited
02 March 2023
 

(LSE: APAX)

 

 

 

Apax Global Alpha Limited

Full year Results for the year ended 31 December 2022

 

 

Key highlights

 

·

AGA's Adjusted NAV was €1.3bn (FY21: €1.5bn) in 2022, and Total NAV Return1 was (7.4)% ((10.7)% constant currency).

·

Operationally, the Private Equity portfolio performed well in 2022, with average EBITDA growth of 18.5%2. However, this was not enough to fully offset negative movements in valuation multiples.

 

·

Negative movements in valuation multiples were primarily from multiple contraction for the Apax Funds' listed holdings which represented 14% of the Private Equity portfolio at 31 December 2022 but contributed c. 80% to the multiple decline in Private Equity. This led to a Total Return in Private Equity decline by (11.3)% in 2022.

 

·

Derived Investments, which mainly consist of debt, delivered a Total Return of 1.9% in 2022, cushioning overall Total Return. This portfolio absorbs cash not invested in Private Equity, enhances the robustness of AGA's balance sheet and provides a steady flow of income to support dividends and an additional source of alpha for AGA.

 

·

Despite a challenging market backdrop, the Apax Funds continued to focus on opportunities where value creation could be achieved through operational improvement. The Apax Funds completed ten new Private Equity investments in the period in which, on a look-through basis, AGA deployed €132.8m.

·

Demand for high-quality assets remained strong and the Apax Funds completed seven full exits in the period at an average uplift of 15.1% to last Unaffected Valuations3.

·

The Board takes a disciplined approach to liquidity and capital management with rigorous scenario modelling and stress testing when agreeing new commitments to the Apax Funds. As a result, AGA was pleased to make commitments to three new funds during 2022: €700m to Apax XI, $60m to Apax Global Impact, and $40m to Apax Mid-Market Opportunities II.

 

·

Dividend of 11.82p per share declared for the full year 2022, in line with AGA's dividend policy of distributing 5% of NAV per annum.

 

Tim Breedon CBE, Chairman of Apax Global Alpha, said:

"Whilst 2022 saw a marked change in the macro environment, the Apax Funds have continued to identify attractive investment opportunities, generate alpha through business improvement, and exit at attractive prices. Whilst no investment strategy can be totally immune to the current macro headwinds, we believe that the Apax Funds have the right investment approach for the current market conditions."

Financial highlights

 

·

AGA was 95% invested as at 31 December 2022 and had unfunded commitments to the Apax Funds (together with recallable distributions) of €1.0bn.

·

At 31 December 2022, AGA's invested portfolio consisted of €871.0m in Private Equity (71%) and €364.2m in Derived Investments (29%).

 

·

Following earlier commitments, as anticipated there were several large capital calls towards the end of 2022, largely from Apax X. After these calls, net cash was €64m, and the €250m revolving credit facility ("RCF") remained undrawn as at 31 December 2022.

·

In early 2023, AGA received formal notice that the RCF will revert to a conventional fixed-term arrangement with an expiry date of 10 January 2025.

 

FY 2022

FY 2022

FY 2021

FY 2022

£

£

Adjusted NAV4

1,299m

1,150m

1,482m

1,247m

Adjusted NAV4 per share

2.65

2.34

3.02

2.54

NAV4 per share

2.65

2.34

3.03

2.55

 

 

Exposure

FY 2022

FY 2022 constant currency

Total NAV Return1

(7.4)%

(10.7)%

Total Return1 - Private Equity

67%

(11.3)%

(14.8)%

Total Return1 - Derived Debt

26%

2.7%

(1.7)%

Total Return1 - Derived Equity

2%

(6.8)%

(7.9)%

Cash & Others

5%

 

 

Portfolio highlights

 

·

Invested portfolio split across four key sectors: Tech & Digital (40%), Services (28%), Healthcare (17%), and Internet/Consumer (15%).

 

·

In Private Equity, the portfolio is well diversified across vintages: 14% invested before 2017, 38% were acquired in the 2017-2019 period, and 48% of investments are from 2020 and later

 

·

The Private Equity portfolio delivered a Total Return1 of (11.3)% ((14.8)% constant currency) in the period. This reflected resilient trading performance with LTM Revenue and EBITDA growth of 21.5%2 and 18.5%2 respectively across the Private Equity portfolio demonstrating their robust business models and the benefit of the Apax Funds' investment approach, offset by the impact of multiple compression on valuations, in particular from the publicly listed holdings held.

 

·

At 31 December 2022, 14% of the Private Equity Invested Portfolio was in publicly listed holdings. These reflect residual stakes in previously IPO'd portfolio companies which, together with secondary sales, have already returned distributions totalling 3.4x initial costs5 to AGA. There is further potential to create value from these holdings, as shown by the sale in January 2023 of the residual holding in Duck Creek at a 57% premium to its end-year market value.

·

In Private Equity, seven full exits were completed during the period with a weighted average uplift of 15.1% compared to last Unaffected Valuations3. Gross IRR6 and Gross MOIC6 in 2022 were 17.1% and 3.1x respectively.

 

·

AGA's debt portfolio, which makes up 94% of Derived Investments, delivered a Total NAV Return of 2.7% in 2022.

 

·

99% of the Derived Debt investments are invested in floating rate loans, reducing duration risk. With increasing base rates, the portfolio generates a 9.9% income yield.

 

·

The average yield to maturity of the portfolio increased to 12.1% at 31 December 2022 (FY21: 6.2%).

 

·

The Derived Debt portfolio has outperformed the S&P/LSTA leveraged loan index7 with a five-year cumulative return on a constant currency basis of 31.2% compared to 17.7%.

 

·

€57.2m was deployed in Derived Debt in 2022. There were no new investments in Derived Equity.

 

For further information regarding the announcement of AGA's FY 2022 Results, including the Company's results presentation and details for today's analyst and investor webcast at 9.30am (UK time), please visit www.apaxglobalalpha.com.

 

Contact details

Katarina Sallerfors, Investor Relations - AGA

Telephone:  +44 207 666 6526

Email: Katarina.sallerfors@apax.com 

 

 

 

APPENDIX

Movements in NAV

 

Adjusted NAV movements (€m)

Private Equity

Derived Investments

Cash

 

Treasury Shares

Facility drawn

Other8

 

Total

Adjusted NAV at 31.12.21

1,012.9

327.2

108.5

-

-

33.1

1,481.7

+ Investments

194.4

57.2

(248.0)

-

-

(3.6)

-

- Distributions/ divestments

(227.8)

(10.5)

271.0

-

-

(32.7)

-

+ Interest and dividend income

-

-

25.3

-

-

(0.3)

25.0

+/- Gains/(losses)

(141.8)

(32.9)

-

-

-

-

(174.7)

+/- FX gains/(losses)9

33.3

14.8

0.2

-

-

-

48.3

+/- Costs and other movements

-

-

(9.5)

-

-

(0.3)

(9.8)

 - Dividends paid

-

-

(71.1)

-

-

-

(71.1)

+/- Performance fee reserve10

-

8.4

-

(8.4)

-

-

-

+/- Shares purchased

-

-

(8.4)

8.4

-

-

-

+/- Revolving credit facility

drawn/repaid

-

-

-

-

-

-

-

Adjusted NAV at 31.12.22

871.0

364.2

68.0

-

-

(3.8)

1,299.4

 

Private Equity - operational metrics

 

Private Equity - operational metrics

FY 22

FY 21

Portfolio year-over-year LTM revenue growth2

21.5%

20.2%

Portfolio year-over-year LTM EBITDA growth2

18.5%

35.3%

Enterprise Value / EBITDA valuation multiple2

17.2x

23.2x

Net debt / EBITDA multiple2

4.8x

4.2x

 

Derived Investments - operational metrics

 

Derived Investments - operational metrics

 

FY 22

FY 21

Debt average income yield to maturity11

 

12.1%

6.2%

Debt average years to maturity

 

5.1

6.1

Debt average income yield12

 

9.9%

5.4%

 

 

Other Invested Portfolio highlights

 

Invested Portfolio analysis13

€m

€m

%

%

- AEVI

2.2

0%

 

- AEVII

23.8

2%

 

- AVIII

88.6

7%

 

- AIX

325.4

26%

 

- AX

364.7

30%

- AXI

(3.4)

0%

- AMI

23.4

2%

 

- AMI II

(0.7)

0%

 

- ADF

48.1

4%

 

- ADF II

0.9

0%

 

- AGI

(2.0)

0%

 

Private Equity

871.0

71%

- Derived Debt

340.6

27%

 

- Derived Equity

23.6

2%

 

Derived Investments

364.2

29%

Total

 

1,316.9

 

100%

 

 

Footnotes

1

"Total NAV Return" means the movement in the Adjusted NAV per share over the quarter plus any dividends paid. "Total Return" reflects the sub-portfolio performance on a stand-alone basis. It excludes items at the overall AGA level such as cash, management fees, and costs

2

Gross Asset Value weighted average of the respective metric across the portfolio. LTM Revenue growth and LTM EBITDA growth rates exclude companies where EBITDA is not meaningful such as financial services or high growth business with fluctuations in EBITDA. Net debt/EBITDA multiple and EV/EBITDA valuation multiple excluded companies where EBITDA is not meaningful such as financial services or high growth business valued on a revenue basis.

3

Valuation uplifts on exits are calculated based on the total actual or estimated sales proceeds and income as appropriate since the last Unaffected Valuation. Unaffected Valuation is determined as the fair value in the last quarter before exit, when valuation is not affected by the exit process (i.e. because an exit was signed, or an exit was sufficiently close to being signed that the Apax Funds incorporated the expected exit multiple into the quarter end valuation). Where applicable, average uplifts of partial exits and IPO's includes proceeds received and the closing fair value at period end.

4

Adjusted NAV reflects Total NAV of €1,299.4m, before performance fee reserve of €0.0m

5

Includes proceeds received from pre-IPO funding rounds, dividends, primary and secondary offerings of shares in companies to 31 December 2022, from companies that listed in 2020 and 2021

6

Private Equity Aggregate Gross IRR and Gross MOIC calculated based on the expected aggregate cash flows in euro across all funds for the deals signed and/or IPO'd in the period. Gross IRR represents concurrent Gross IRR.

7

Source: Bloomberg

8

Other reflects net current liabilities.

9

FX on cash includes the revaluation of cash balances and net gain or losses arising from the differences in exchange rates between transaction dates and settlement dates, and unrealised net gains or losses arising from the translation into euro of assets and liabilities (other than investments) which are not denominated in euro

10

Movement in the performance fee reserve reflects the performance fee reserve accrued by the Company's at 31 December 2022. This does not represent the underlying Private Equity portfolio's carried interest.

11

Gross Asset Value weighted average of the respective metric across the Derived Debt portfolio.

12

Gross Asset Value weighted average of the current full year income (annual coupon/clean price as at the respective date) for each debt position in the Derived Debt portfolio as at the respective date

13

Invested Portfolio excludes cash and cash equivalents, revolving credit facility drawn and net current assets, including these the NAV was €1,299.4m and Adjusted NAV was €1,299.4m reflecting adjustment of €0.0m for the estimated performance fee reserve accrued.

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax" or "the Investment Adviser"

 

2.

Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR")

 

3.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions

 

4.

The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States

 

5.

This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement.

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax's Private Equity activities.

 

Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax") is a leading global private equity advisory firm. For 50 years, Apax has worked to inspire growth and

ideas that transform businesses. The firm has raised and advised funds with aggregate commitments of more than $65 billion. The Apax

Funds invest in companies across four global sectors of Tech, Services, Healthcare, and Internet/Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. For further information about Apax, please visit www.apax.com.

 

Apax is authorised and regulated by the Financial Conduct Authority in the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR UPUWGWUPWGBG
Date   Source Headline
2nd Mar 20237:00 amRNS2022 Final Results
2nd Feb 20237:00 amRNSApax Funds’ Valuations and Credit Facility update
2nd Feb 20237:00 amRNSThe Apax Digital Fund II invests in Magaya
24th Jan 202310:15 amEQSHardman & Co Q&A on Apax Global Alpha (APAX): Adding value to private companies
13th Jan 202311:10 amEQSHardman & Co Research on Apax Global Alpha (Initiation of coverage): Making pearls out of oysters
13th Jan 20237:00 amRNSDuck Creek Technologies to be acquired by Vista
10th Nov 20227:00 amRNSApax IX sells stake in Kepro
4th Nov 20227:00 amRNSQuarterly Results for 30 September 2022
22nd Sep 20227:00 amRNSApax IX agrees to sell stake in Authority Brands
14th Sep 20227:00 amRNSThe Apax Digital Fund II invests in Xeneta
19th Aug 20227:00 amRNS2022 Interim Dividend
19th Aug 20227:00 amRNS2022 Interim Report and Accounts
19th Aug 20227:00 amRNS2022 Interim Results Highlights
5th Aug 20227:00 amRNSApax Funds’ Valuations as at 30 June 2022
26th Jul 20227:00 amRNSFunds advised by Apax to acquire Pickles Auctions
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSProposed commitment to Apax XI
17th Jun 20227:00 amRNSDirector Declaration - Additional Directorship
10th Jun 20227:00 amRNSFunds Advised by Apax Sell Stake in MyCase
7th Jun 20227:00 amRNSFunds advised by Apax to acquire EcoOnline
13th May 20224:02 pmRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSDirector/PDMR Shareholding
6th May 20227:00 amRNSResult of AGM
6th May 20227:00 amRNSIncrease to the Revolving Credit Facility
6th May 20227:00 amRNSQuarterly results for 31 March 2022
7th Apr 20227:00 amRNSProposed commitment to AMI Opportunities Fund II
22nd Mar 20227:00 amRNSApax Digital Funds invest in ClearBank
17th Mar 20223:59 pmRNSPurchase of Ordinary Shares under IM Agreement
8th Mar 20227:00 amRNSProposed commitment to Apax Global Impact Fund
2nd Mar 20227:00 amRNSKey Information Document
2nd Mar 20227:00 amRNS2021 Annual Dividend Declaration
2nd Mar 20227:00 amRNSNotice of AGM
2nd Mar 20227:00 amRNS2021 Annual Report and Accounts
2nd Mar 20227:00 amRNS2021 Final Results
14th Feb 20227:00 amRNSApax X invests in Alcumus and Ole Smoky
3rd Feb 20227:00 amRNSApax Funds’ Valuations as at 31 December 2021
31st Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Dec 202110:30 amRNSDirector Declaration
17th Dec 20219:30 amRNSDirector Declaration
6th Dec 20217:00 amRNSFunds advised by Apax sell stakes in Unilabs
9th Nov 20217:00 amRNSInmarsat agrees combination with Viasat
4th Nov 20217:00 amRNSQuarterly results for 30 September 2021
2nd Nov 20217:00 amRNSFunds advised by Apax announce investment in Lever
1st Nov 20217:00 amRNSApax Funds to acquire HSG
6th Oct 20217:00 amRNSApax Funds to acquire Eating Recovery Center
16th Sep 20217:00 amRNSInitial Public Offering of Thoughtworks
8th Sep 20217:00 amRNSFunds advised by Apax to invest in T-Mobile
2nd Sep 20217:00 amRNSWizeline Acquired by CDPQ
1st Sep 20217:00 amRNSFunds advised by Apax to acquire SavATree
31st Aug 20215:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.